Voltage-gated ion channel

Kv7.2/Kv7.3 (KCNQ2/3, M-channel)

Voltage-gated potassium channel, Kv7.2/Kv7.3 heteromer (M-current)

  • GeneKCNQ2/KCNQ3
  • FamilyVoltage-gated potassium channels
  • GroupKv7 potassium channels
  • TypeA defined subunit combination.

Kv7.2 and Kv7.3 subunits coassemble into a heteromeric channel whose kinetics, pharmacology and expression pattern are consistent with the native M-current. The KCNQ2 gene was identified in 1998 in a chromosome 20 deletion that co-segregated with seizures in a family with benign familial neonatal convulsions, a dominantly inherited epilepsy of newborns, and five other probands of such families had KCNQ2 mutations. Mutations in KCNQ3 can cause the same disorder.1,2,3 Gabapentin activates the Kv7.2/Kv7.3 heteromer in the nanomolar range, while the related gabapentinoid pregabalin does not activate it and inhibits it at higher concentrations.4

Sources (4)
  1. Wang et al. 1998Wang HS, Pan Z, Shi W, et al. (1998) KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel Science
  2. Singh et al. 1998Singh NA, Charlier C, Stauffer D, et al. (1998) A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns Nat Genet
  3. Schroeder et al. 2000Schroeder BC, Hechenberger M, Weinreich F, et al. (2000) KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents J Biol Chem
  4. Manville et al. 2018Manville RW, Abbott GW (2018) Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels Mol Pharmacol

Functional potency (EC₅₀)

1 substance, 1 displayed value. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.

Human

1 measurement
  • GabapentinAgonist4.2 nMManville et al. 2018
    Assay
    human KCNQ2/3 (Kv7.2/7.3) expressed in Xenopus oocytes, two-electrode voltage clamp, current activation
    Shown value from
    Manville et al. 2018, Results text

Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.